Home Cart Sign in  
Chemical Structure| 151433-25-9 Chemical Structure| 151433-25-9

Structure of 151433-25-9

Chemical Structure| 151433-25-9

*Storage: Inert atmosphere, 2-8°C.

*Shipping: Normal

(1R,2R)-1,2-Bis[[[3,5-bis(tert-butyl)-2-hydroxyphenyl]methylene]amino]cyclohexane

CAS No.: 151433-25-9

4.5 *For Research Use Only !

Cat. No.: A1149287 Purity: 98%

Change View

Size Price

US Stock

Global Stock

In Stock
1g łÇͶÊÊ In Stock In Stock Login
5g łÇó¶ÊÊ In Stock In Stock Login
25g łòʶÊÊ In Stock In Stock Login

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • 1g

    łÇͶÊÊ

  • 5g

    łÇó¶ÊÊ

  • 25g

    łòʶÊÊ

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 151433-25-9 ]

CAS No. :151433-25-9
Formula : C36H54N2O2
M.W : 546.83
SMILES Code : OC1=C(C(C)(C)C)C=C(C(C)(C)C)C=C1/C=N/[C@H]2[C@H](/N=C/C3=CC(C(C)(C)C)=CC(C(C)(C)C)=C3O)CCCC2
MDL No. :MFCD00191800
InChI Key :FYNXDGNCEBQLGC-LOYHVIPDSA-N
Pubchem ID :2733339

Safety of [ 151433-25-9 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H315-H319-H332-H335
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Application In Synthesis of [ 151433-25-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 151433-25-9 ]

[ 151433-25-9 ] Synthesis Path-Downstream   1~37

  • 1
  • [ 37942-07-7 ]
  • [ 20439-47-8 ]
  • [ 151433-25-9 ]
YieldReaction ConditionsOperation in experiment
Heating / reflux; Chiral ligands were prepared by refluxing 1 ,2-cyclohexyldiamines {R,R and S1S) with 2,4 di-.erf-butyl salicylaldehyde
In ethanol; for 12h;Reflux; 1.14 g of (R,R)-1,2-cyclohexanediamine was dissolved in 20 mL of ethanol.4.7 g of 3,5-di-tert-butylsalicylaldehyde in 30 mL of ethanol solution was slowly added dropwise thereto.The resulting mixed solution was refluxed for 12 h.Obtaining a reaction mixture; removing the reaction solvent by filtration,The obtained reaction product ethanol was recrystallized to obtain a Schiff base ligand.The present invention performs elemental analysis on the obtained Schiff base compound,Obtaining the content of each atom therein,The results are as follows: Elem.Anal. (%): Calcd. C 79.07; H 9.95; N5.12.Found: C 78.71; H 9.85; N 4.77. this means,The Schiff base ligand obtained in this embodiment has the structure of formula II,Wherein Y is ((R,R)-1,2-cyclohexanediamine) and R is a tert-butyl group.
General procedure: In a round bottomed flask filled with argon, (1R,2R)-trans-1,2-diaminocyclohexane (R,R-DACH) (1 equiv.) and potassium carbonate (0.9 equiv.) were dissolved in 3mL of distilled water and heated for 30min at 80-85C. The exact amounts are given below. Subsequently, a solution of aldehyde (2 equiv.) in 45mL of ethanol was added dropwise and the reaction mixture was stirred for 3h. The solution turned yellow. After this time, ethanol was evaporated and 10mL of distilled water was added. Water solution was extracted with dichloromethane 3 times with 30mL of the solvent. The combined extracts were washed with brine and dried with anhydrous Na2SO4. After filtration of the drying agent, solution was evaporated to dryness. The resulting salens were subsequently reduced without purification. The resulting salens were dissolved in methanol (300mL or more if it was necessary for complete dissolution). To the salen solution, sodium borohydride (4 equiv.) was added in portions at room temperature. After addition of NaBH4, the reaction mixture was stirred for 3h and then 30mL of water was added and stirred for 15min. The alcohol was evaporated under vacuum and the water residue was extracted with DCM three times for 30mL. Organic phase was dried with Na2SO4 and after removing of the desiccant, the solvent was evaporated.
  • 3
  • [ 151433-25-9 ]
  • VO-Salen-Komplex [ No CAS ]
YieldReaction ConditionsOperation in experiment
96% With vanadyl(IV) sulphate pentahydrate; In ethanol; for 3h;Heating / reflux; 5,46 g (0.01 mol) (R, R)-2, 2'- [1, 2-CYCLOHEXANDIYL) bis (nitrilomethylidyn)] bis [4,6-di- tert.-butyl)-phenol] werden in 50 ml Ethanol vorgelegt und mit 1,14 g (0,0045 mol) VANADYLSULFAT-PENTAHYDRAT versetzt. Nach drei Stunden unter Rückfluss und vollständigem Umsatz (DC-Kontrolle) wird das Lösungsmittel abdestilliert, der Rückstand in 200 mi Dichlormethan aufgenommen und die Lösung mit 100 mi Wasser gewaschen. Nach Phasentrennung, Trocknen der Lösung mit Natriumsulfat und Abdestillieren des Lösungsmittels erhält man 5,0 g HELLGRüNES, amorphes Pulver (Ausbeute : 96 % der Theorie). Der vorliegende VA0-SALEN- Komplex kann in Form des vorliegenden Rohprodukts oder, falls gewünscht, nach Reinigung durch Chromatographie eingesetzt werden. SCHMELZPUNKT 208 C (ZERS. ), [A] D20 =-300 (C = 0,01 ; CHCIS), PARAMAGNETISCH. IR (KBr), v = 2950 (s), 2870 (m), 2350 (w), 2320 (w), 1610 (vs), 1550 (m), 1270 (s) [CM-'].
  • 4
  • oxo disulfato vanadate (IV) (2-) [ No CAS ]
  • [ 64-17-5 ]
  • [ 151433-25-9 ]
  • C38H58N2O4V(1+)*HO4S(1-) [ No CAS ]
YieldReaction ConditionsOperation in experiment
53% for 2h;Heating / reflux; Solutions of (1R,2R)-N,N'-bis(3,5-di-tert-butylsalicyliden)-1,2-cyc- lohexanediamine (1.0 g, 1.8 mmol) in THF (20 mL) and vanadyl sulphate hydrate (0.55 g, 2.0 mmol) in hot ethanol (32 ml) were mixed and stirred under reflux for 2 h in air, then the solvent was removed in vacuo. The residue was dissolved in dichloromethane and put atop a SiO 2 filled column. Elution first with dichloromethane, then with EtOAc: methanol (2:1) gave a catalyst of formula 3b wherein R 1 R 2=tBu, R 3&R 4 --(CH 2) 4-- (0.6 g, 53%) as a dark-green crystalline solid. It can be additionally recrystallized from benzene-CH 2Cl 2. [α] D 23 -914.29 (c=0.01, CHCl 3); ν max (KBr, cm -1): 1618 (ν CH N); 1250 (ν HSO4); 965 (ν V O); δ H (CDCl 3): 0.83 (3H, t), 1.33 (18H, s), 1.49 (18H, s), 1.7-2.2 (8H, m), 3.41 (2H, q), 3.81 (1H, m), 4.26 (1H, m), 7.49 (1H, s), 7.52 (1H, s), 7.68 (1H, s), 7.73 (1H, s), 8.53 (1H, s), 8.73 (1H, s)
  • 5
  • bis(trimethylsilyl)amide yttrium(III) [ No CAS ]
  • [ 151433-25-9 ]
  • YC6H10(NCHC6H2(C(CH3)3)2O)2N(Si(CH3)3)2 [ No CAS ]
  • 6
  • tris(bis(trimethylsilyl)amido)ytterbium(III) [ No CAS ]
  • [ 151433-25-9 ]
  • YbC6H10(NCHC6H2(C(CH3)3)2O)2N(Si(CH3)3)2 [ No CAS ]
  • 7
  • tris(bis(trimethylsilyl)amido)lanthanum(III) [ No CAS ]
  • [ 151433-25-9 ]
  • LaC6H10(NCHC6H2(C(CH3)3)2O)2N(Si(CH3)3)2 [ No CAS ]
  • 8
  • [ 151433-25-9 ]
  • tris(bis(trimethylsilyl)amido)praseodymium(III) [ No CAS ]
  • PrC6H10(NCHC6H2(C(CH3)3)2O)2N(Si(CH3)3)2 [ No CAS ]
  • 9
  • [ 75-24-1 ]
  • [ 151433-25-9 ]
  • C6H10(NCHC6H2(C(CH3)3)2OAl(CH3)2)2 [ No CAS ]
  • 10
  • [ 75-24-1 ]
  • [ 151433-25-9 ]
  • (R,R)-[Salen-t-Bu]AlMe [ No CAS ]
  • 11
  • [ 1184-58-3 ]
  • [ 151433-25-9 ]
  • C6H10(NCHC6H2(C(CH3)3)2OAl(CH3)Cl)2 [ No CAS ]
  • 12
  • [ 1184-58-3 ]
  • [ 151433-25-9 ]
  • (R,R)-N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum(III) chloride [ No CAS ]
  • 13
  • [ 10025-73-7 ]
  • [ 151433-25-9 ]
  • ((R,R)-(-)-N,N'-bis(3,5-di-tert-butyl-salicylidenate)-1,2-cyclohexane-diamine)Cr(II) complex [ No CAS ]
  • 14
  • [ 96-10-6 ]
  • [ 151433-25-9 ]
  • (R,R)-N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum(III) chloride [ No CAS ]
  • 15
  • lead(II) bis(trimethylsilyl)amide [ No CAS ]
  • [ 151433-25-9 ]
  • [(R,R)-[2,2'-[1,2-cyclohexanediylbis[(nitrilo)methylidyne]]bis[4,6-bis(1,1-dimethylethyl)phenolato]](2-)]-lead(II) [ No CAS ]
  • 16
  • [ 59863-12-6 ]
  • [ 151433-25-9 ]
  • [(R,R)-[2,2'-[1,2-cyclohexanediylbis[(nitrilo)methylidyne]]bis[4,6-bis(1,1-dimethylethyl)phenolato]](2-)]-germanium(II) [ No CAS ]
  • 17
  • [ 55147-78-9 ]
  • [ 151433-25-9 ]
  • [(R,R)-[2,2'-[1,2-cyclohexanediylbis[(nitrilo)methylidyne]]bis[4,6-bis(1,1-dimethylethyl)phenolato]](2-)]-tin(II) [ No CAS ]
  • 19
  • Ru(4+)*3Cl(1-)*NO(1-)*H2O=[RuCl3(NO)(H2O)] [ No CAS ]
  • [ 151433-25-9 ]
  • [ 67-64-1 ]
  • [Ru(R,R-(-)-1,2-cyclohexanebis(3,5-di-tert-butyl)salicylideneaminate)(NO)(Cl)]*C3H6O [ No CAS ]
  • 20
  • [ 110-86-1 ]
  • [ 52462-29-0 ]
  • [ 151433-25-9 ]
  • [Ru((bis(3,5-di-tert-butylsalicylidene)-(1R,2R)-cyclohexanediamine)-2H)(pyridine)2] [ No CAS ]
  • 21
  • [ 557-20-0 ]
  • [ 151433-25-9 ]
  • (R,R)-(-)-1,2-cyclohexanediamino-N,N'-bis(3-tert-butyl-5-(4-pyridyl)salicylidene) zinc(II) [ No CAS ]
  • 22
  • cobalt(II) acetate [ No CAS ]
  • [ 151433-25-9 ]
  • (R,R)-(-)-N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) [ No CAS ]
  • 23
  • [ 16997-54-9 ]
  • [ 151433-25-9 ]
  • (1R,2R) N,N′-bis(3,5-di-tertbutylsalicylidene)-1,2-cyclohexanediamino chromium(III) chloride [ No CAS ]
  • 24
  • chromium dichloride [ No CAS ]
  • [ 151433-25-9 ]
  • (1R,2R) N,N′-bis(3,5-di-tertbutylsalicylidene)-1,2-cyclohexanediamino chromium(III) chloride [ No CAS ]
  • 25
  • [ 288-32-4 ]
  • [ 7791-07-3 ]
  • [ 75-09-2 ]
  • [ 6147-53-1 ]
  • [ 151433-25-9 ]
  • [Co(III)(di-3,5-tert-butylsalicylidene-1,2-diaminocyclohexane)(2-)(imidazole)2](ClO4)*CH2Cl2 [ No CAS ]
  • 26
  • [ 7791-07-3 ]
  • [ 693-98-1 ]
  • [ 6147-53-1 ]
  • [ 151433-25-9 ]
  • [Co(III)(di-3,5-tert-butylsalicylidene-1,2-diaminocyclohexane)(2-)(2-methylimidazole)2](ClO4) [ No CAS ]
  • 27
  • [ 555-31-7 ]
  • [ 151433-25-9 ]
  • ((R,R)-N,N'-bis(3,5-bis(tert-butyl)-2-oxy-benzylidene)-1,2-diaminocyclohexane)(isopropoxide)aluminum [ No CAS ]
  • 28
  • [ 555-31-7 ]
  • [ 151433-25-9 ]
  • (1R,2R)-(cyclohexyl-salen)Al(O-i-Pr) [ No CAS ]
  • 29
  • [ 616-47-7 ]
  • [ 7791-07-3 ]
  • [ 6147-53-1 ]
  • [ 151433-25-9 ]
  • [Co((R,R)-N,N-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine(-2H))(N-methylimidazole)2](ClO4) [ No CAS ]
  • 30
  • [ 97-93-8 ]
  • [ 151433-25-9 ]
  • [Al(C2H5)(C36H52N2O2)] [ No CAS ]
  • 31
  • iron(III) chloride tertahydrate [ No CAS ]
  • [ 151433-25-9 ]
  • [(Fe(C36H52N2O2))2O] [ No CAS ]
  • 32
  • vanadyl(IV) sulfate hydrate [ No CAS ]
  • [ 151433-25-9 ]
  • (O)V(S,S)-N,N'-bis-(3,5-di-tert-butylsalicylidene)-1,2-cyclohexenediamine-2H) [ No CAS ]
  • 33
  • vanadyl(IV) sulfate hydrate [ No CAS ]
  • [ 64-17-5 ]
  • [ 151433-25-9 ]
  • (VO(C6H10(NCHC6H2(C(CH3)3)2O)2)(H2O))(1+)*C2H5OSO3(1-)*H2O=(VO(C6H10(NCHC6H2(C(CH3)3)2O)2)(H2O))(C2H5OSO3)*H2O [ No CAS ]
  • 34
  • [ 3153-26-2 ]
  • [ 151433-25-9 ]
  • (O)V(S,S)-N,N'-bis-(3,5-di-tert-butylsalicylidene)-1,2-cyclohexenediamine-2H) [ No CAS ]
  • 35
  • [ 151433-25-9 ]
  • copper dichloride [ No CAS ]
  • [Cu(C36H52N2O2)] [ No CAS ]
  • 36
  • [ 151433-25-9 ]
  • nickel dichloride [ No CAS ]
  • Ni((R,R)-N,N-bis(3,5-di-tert-butylsalicylidene)cyclohexane-1,2-diamine) [ No CAS ]
  • 37
  • [ 75-24-1 ]
  • [ 151433-25-9 ]
  • (R,R)-N,N'-bis(3,5-di-tert-butyl-salicylidene)-1,2-cyclohexanediamino methylaluminium [ No CAS ]
 

Historical Records

Technical Information

Categories